-+ 0.00%
-+ 0.00%
-+ 0.00%
Ocugen to present modifier gene therapy platform at Piper Sandler Virtual Ophthalmology Day
Share
Listen to the news
Ocugen to present modifier gene therapy platform at Piper Sandler Virtual Ophthalmology Day
  • Ocugen will join July investor and industry conferences to highlight its modifier gene therapy platform.
  • Piper Sandler Virtual Ophthalmology Day fireside chat set for July 10, 2026.
  • OIS Retina Innovation Summit panel appearance scheduled for July 14, 2026 in Montreal.
  • ASRS meeting presentations on OCU410 trial results slated for July 17, 2026 in Montreal.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocugen Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607010700PRIMZONEFULLFEED9754813) on July 01, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending